Pre-Conference Workshop

Psychedelics in Clinical Practice

Moderator: Dr. Derrick M. DeSilva, Jr., MD, Associate Attending Staff Dept. of Medicine, Raritan Bay Medical Center (RBMC) and Teaching Faculty, JFK Medical Center

The Convergence of Cannabis and Psychedelics

Dr. Kelly King, MD, Chief Medical Officer, ReleafMD

Ayahuasca: A journey Of A Western Physician Into Amazonian Scared Medicine

Dr. Raphael Bones, Chief Medical Officer, Prixus Medical Group

Psilocybin as an Adjunct Therapy for Chronic Conditions

Dr. Uma Dhanabalan, MD, MPH, FAAFP, MRO, CMS, Founder/ CEO of Global Health & Hygiene Solutions, LLC / UPLIFTING Health & Wellness

The Use of Psilocybin and PTSD: A Veteran's Perspective

Joshua Linney, Founder/CEO, Carma Corps

Workshop Abstract:

The psychedelic effects of some plants and fungi have been known and deliberately exploited by humans for thousands of years. Fungi, particularly mushrooms, are the principal source of naturally occurring psychedelics. Psychedelic use was largely associated with the “hippie” counterculture movement, which, in turn, resulted in a growing, and still lingering, negative stigmatization for psychedelics. As a result, in 1970, the U.S. government rescheduled psychedelics as Schedule 1 drugs, ultimately ending scientific research on psychedelics. Since then, significant advances have been made in characterizing the chemical properties of some of these psychedelic compounds as well as their therapeutic uses. This presentation will explore the potential of the role for psychedelics in the treatment of a variety of neuropsychiatry-related conditions (depression, anxiety, addiction, PTSD, OCD etc.) especially during this time of COVID, and examine recent advances as well as current research in this newly emerging field of therapeutics.

Learning Objectives:

Describe how many natural of the psychedelics can play a significant role in the treatment of various neuropsychiatric disorders
How psychedelics can be used in a safe treatment environment to improve quality of life

Dr. DeSilva's Bio:

• Associate Attending Staff, Dept. of Medicine, Raritan Bay Medical Center(RBMC), Perth Amboy, NJ

• Teaching Faculty JFK Medical Center, Edison, NJ

• Past-Chairman of Planning Com. Age Management Medicine Group (AMMG)

• Past President of American Nutraceutical Association

• Recipient of the Alan Mintz Award for Excellence in Clinical Age Management Medicine

• Best Doctor Award by Castle Connolly for the past 19 consecutive years

• Host of “Ask the Doctor” on WCTC Radio, NJ • Medical correspondent for Cablevision (News 12 NJ) and Host of “Health Matters”

Dr. Kelly King, MD

Presentation Title:

The Convergence of Cannabis and Psychedelics

Dr. Kelly King, MD, Chief Medical Officer, ReleafMD

Abstract:

Current uses of Cannabis and psychedelics in clinic practice, patient outcomes and benefits of using cannabis and psychedelics in patients with specific conditions

Bio:

A disabled Air Force veteran and co-founder of Releaf MD, The Center for Medical Marijuana, Dr. Kelly King is a board-certified internal medicine physician and a graduate of the University of Tennessee, School of Medicine. She has used her experience and influence as a Hospitalist, Hospice, Palliative, and Geriatric Care Provider to become a key influencer within the medical cannabis industry. She is licensed and registered to tailer safe treatment plans for medical cannabis patients in Florida, New York, and California.

Dr. Raphael Bones, MD

Presentation Title:

Ayahuasca: A journey Of A Western Physician Into Amazonian Scared Medicine

Dr. Raphael Bones, Chief Medical Officer, Prixus Medical Group

Abstract:

To Be submitted.

Bio:

Dr. Raphael Bones was born and raised in beautiful Guayanilla Bay, Puerto Rico. He grew up in a family that enjoys fishing and water sports. While attending the University of Puerto Rico, he joined the US Navy as he felt committed to serving his country. At the birth of the new millennia he graduated from the Universidad Central Del Caribe Medical School. After completing two years of the General Surgery residency program in Puerto Rico he changed his goals and decided to complete his residency in Internal Medicine in 2005. As a physician, he has experience in various settings including Emergency Room, as a Hospitalist, and as a Primary Care Provider in outpatient clinics. Dr. Bones is currently a member of The American Medical Association, The Florida Medical Association, The American Association for Physician Leadership, and The American Academy of Anti-Aging Medicine. In 2015 Dr. Bones joined Prixus Medical to practice primary care with integrative functional medicine. Now he enjoys practicing medicine the way he envisions it and in his spare time he loves playing golf and boating in the Florida coast waters.

2000 - Universidad Central Del Caribe Medical School

2005 - Internal Medicine

2014 - Integrative and Anti-Aging Medicine

2016 - Medical Cannabis

2023 - Integrative Psychiatry Institute (currently)

Dr. Uma Dhanabalan, MD

Presentation Title:

Psilocybin as an Adjunct Therapy for Chronic Conditions

Dr. Uma Dhanabalan, MD, MPH, FAAFP, MRO, CMS, Founder/ CEO of Global Health & Hygiene Solutions, LLC / UPLIFTING Health & Wellness

Abstract:

Learning Objectives:

1) What schedule is psilocybin in today and what does it mean?

2) What is psilocybin?

3) What three chronic conditions psilocybin can be used for?

Bio:

Dr. Uma Dhanabalan is a highly respected, Harvard trained physician known to most as Dr. UmaTM. She is the Founder/CEO of Global Health & Hygiene Solutions, LLC established in 2006 with a mission to “promote wellness and prevent illness”™ and Uplifting Health & Wellness, an Independent Medical Concierge Practice. Dr. Uma’s mission is to change the stigma regarding Cannabis and for the world to know about the Endocannabinoid system through education. She is an educator, advocate, activist and speaks locally & globally about cannabis as a plant medicine and a global solution.

She created the model TotalHealthCareTHC™ where she “Educates, Embraces and Empowers” her patients, the public and policymakers, etc. and promotes cannabis as a treatment option. She created “Doc and Jocks”™ with Dr. Uma as The “Doc” and various famous athletes as The “Jocks”, that are using cannabis to promote her mission and the message that there is an athlete in all of us. Dr. Uma Says®, “Cannabis is not for everyone, yet it should be a first line option not the last resort,” “Cannabis is an entrance to a better quality of life, an exit drug from pharmaceuticals, narcotics, alcohol, and nicotine.” “Safety First, Do No Harm.” “Cannabis The Exit Drug®”

She has received awards from the American College of Occupational & Environmental Medicine for her research project: “Occupational & Environmental Exposure to Lead in South India”, from The 7th World Ayurveda Conference & Arogya Expo for her presentation “Cannabis & The Therapeutic Uses", The Educational Achievement Award presented by Clover Leaf at Cannabis Business Award 2017, Award from High Times Inaugural Female 50, The International Cannabis Activist Award at The 10th Anniversary Cannabis Business Awards 2022 , Cannabis Philanthropist Award 2022-2023, “Blood, Sweat & Tears” from the Crohn’s Charity Service Foundation and most recently, the 2023 Warrior Women Award presented by Etain and The JUSTUS Foundation.

She received her Bachelor of Arts with High Honors from Rutgers University; her Medical Degree from the University of Medicine & Dentistry; her Family Practice Residency at the Medical University of South Carolina; her Masters in Public Health, Occupational & Environmental Medicine Residency, and Fellowship in Heavy Metals at the Harvard School of Public Health.

She is a Fellow of the American Academy of Family Physicians, a Diplomat of the American Academy of Cannabinoid Medicine as a Cannabinoid Medicine Specialist and Certified by the Medical Review Officer Certification Council as a Medical Review Officer.